NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
Scientists Just Discovered a Surprising Health Risk of a High-Protein Diet
Reviewed by Dietitian Emily Lachtrupp, M.S., RD Design elements: Getty Images. EatingWell design. Key Points A new study…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q3 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…